Syngeneic models, involving the implantation of Panc02 [23] or KrasG12D; Trp53R172H; Pdx-1-Cre (KPC)-derived cell lines into immunocompetent mice, allow for the study of tumor-immune interactions in genetically matched hosts [24] (Figure 2D). This evidence concerns the gene PDX1 and neoplasm.